| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 02/07/2008 | US20080032946 Method for producing a composite made of oligonucleotides or polynucleotides and hydrophobic biodegradable polymers as well as composite obtained according to the method |
| 02/07/2008 | US20080032945 2'-modified oligonucleotides |
| 02/07/2008 | US20080032944 Target Nucleic Acid Of Retrovirus Integration |
| 02/07/2008 | US20080032942 double-stranded (siNA) molecule that down-regulates expression of a beta-secretase (BACE) gene |
| 02/07/2008 | US20080032940 Methods for reducing anthracycline-induced toxicity |
| 02/07/2008 | US20080032939 Iridoid-saccharide compound and method of using same |
| 02/07/2008 | US20080032938 treating acne or reducing the appearance of oil or pores on the skin, hair and scalp, comprising topical administration of 2'-hydroxy-2,3,5'-trimethoxychalcone, and optionally salicylic acid or benzoyl peroxide and a catechin |
| 02/07/2008 | US20080032937 Bioavailability and Improved Delivery of Alkaline Pharmaceutical Drugs |
| 02/07/2008 | US20080032934 Compositions for prevention of adhesions and other barrier applications |
| 02/07/2008 | US20080032933 Type V Phosphodiesterase Inhibitors and Natriuretic Polypeptides |
| 02/07/2008 | US20080032925 Method for Modulating Inflammatory Responses by Altering Plasma Lipid Levels |
| 02/07/2008 | US20080032924 Antifungal Peptides |
| 02/07/2008 | US20080032923 Effective Use Method Of Medicaments And Method Of Preventing Expression Of Side Effect |
| 02/07/2008 | US20080032921 Inducing immune responses to influenza virus using polypeptide and nucleic acid compositions |
| 02/07/2008 | US20080032920 Macromolecules modified with electrophilic groups and methods of making and using thereof |
| 02/07/2008 | US20080032918 Gene expression or biosynthesis inhibition by locally administering inhibitors of angiotensin-converting enzyme, angiotensin type 1 receptors, or sodium-hydrogen exchange type-1 proteins; antiinflammatory agents, myocardial antiischemic agents, anaphylaxis; sustained release implants, stents, inhalers |
| 02/07/2008 | US20080031986 Protein kinase modulation by hops and acacia products |
| 02/07/2008 | US20080031985 Annatto Extract Compositions, Including Geranyl Geraniols And Methods Of Use |
| 02/07/2008 | US20080031977 Pharmaceutical compositions comprising cannabigerol |
| 02/07/2008 | US20080031976 Multivitamin formulations for promoting healthy collagen, and methods of their use |
| 02/07/2008 | US20080031967 Compositions, products and methods for controlling weight in a mammal |
| 02/07/2008 | US20080031965 Oral Preparations and Process for Production Thereof |
| 02/07/2008 | US20080031964 Combination therapeutic compositions and method of use |
| 02/07/2008 | US20080031963 Method of treating pain by administering 24 hour oral opioid formulations exhibiting rapid rate of initial rise of plasma drug level |
| 02/07/2008 | US20080031961 Benefit agent containing delivery particle |
| 02/07/2008 | US20080031959 Anti-migraine oral spray formulations and methods |
| 02/07/2008 | US20080031958 Composition for accelerating bone fracture healing |
| 02/07/2008 | US20080031957 Pulmonary delivery of 1alpha,25-dihydroxyvitamin D3 and co-administration of parathyroid hormone or calcitonin |
| 02/07/2008 | US20080031956 Bioimplant formulation |
| 02/07/2008 | US20080031955 Product Comprising a Beta-Lactam Antibiotic |
| 02/07/2008 | US20080031951 Compositions and methods for the inhibition of phospholipase A2 |
| 02/07/2008 | US20080031949 High dose orally dissolvable/disintegrable lyophilized dosage form |
| 02/07/2008 | US20080031948 admixed with hydroxyalkylcellulose, polyvinylacetate, blends of polyvinylacetate and polyvinylpyrrolidone, a vinylpyrrolidone copolymer and polyethylene oxide; enteric coating |
| 02/07/2008 | US20080031947 Orally dissolvable/disintegrable lyophilized dosage forms containing protected |
| 02/07/2008 | US20080031944 Stabilization of lorazepam |
| 02/07/2008 | US20080031943 Immediate-release tablet formulations of a thrombin receptor antagonist |
| 02/07/2008 | US20080031942 Solid Preparation |
| 02/07/2008 | US20080031941 Gastric acid secretion inhibiting composition |
| 02/07/2008 | US20080031939 Process for the preparation of armodafinil |
| 02/07/2008 | US20080031936 Immunostimulatory nucleic acid molecules |
| 02/07/2008 | US20080031935 Cholinesterase Inhibitors In Liposomes And Their Production And Use |
| 02/07/2008 | US20080031933 Transparent transdermal nicotine delivery devices |
| 02/07/2008 | US20080031932 Transdermal atomoxetine formulations and associated methods |
| 02/07/2008 | US20080031931 Organotellurium and selenium-based antimicrobial formulations and articles |
| 02/07/2008 | US20080031929 Liquid bandage |
| 02/07/2008 | US20080031926 Administering to birds and snimals in need of contraception an nicarbazin and a carrier; inhibition of zona pellucida protein C (ZPC), measuring ZPC, and stopping administration to reversibly restore ZPC; added to feed; nontoxic; efficiency |
| 02/07/2008 | US20080031922 comprising a core and a membrane encasing it; for controlling the initial burst of therapeutically active agent from a delivery system that consists of at least one elastomer; an implant, intravaginal, intracervical or intrauterine device or transdermal patch |
| 02/07/2008 | US20080031919 Vasoocclusive microcoil including a radiopaque metal wire, the outer surface of which has pores with complex shapes containing a plastic agent that acts to accelerate healing once the coil is in place |
| 02/07/2008 | US20080031918 Barriers for polymeric coatings |
| 02/07/2008 | US20080031916 Dendrimer cross-linked collagen |
| 02/07/2008 | US20080031907 Cosmetic and pharmaceutical foam |
| 02/07/2008 | US20080031905 Method for treatment of burns |
| 02/07/2008 | US20080031904 Combination consisting of a magnesium preparation having a prolonged release and of another active substance, and use thereof in the fields of cosmetics, therapeutics and/or nutrition |
| 02/07/2008 | US20080031903 Method of treating ocular infections |
| 02/07/2008 | US20080031901 Sustained release monoeximic formulations of opioid and nonopioid analgesics |
| 02/07/2008 | US20080031898 Compositions and methods to increase the effect of a neurotoxin treatment |
| 02/07/2008 | US20080031886 Viruses for the treatment of cellular proliferative disorders |
| 02/07/2008 | US20080031884 Compositions and methods for treating, reducing, ameliorating, or alleviating posterior-segment ophthalmic diseases |
| 02/07/2008 | US20080031883 Condition-dependent, multiple target delivery system |
| 02/07/2008 | US20080031880 Use of ErbB receptor ligands in treating diabetes |
| 02/07/2008 | US20080031869 Pain relief composition |
| 02/07/2008 | US20080031865 Product and process for liquefaction of mucus or sputum |
| 02/07/2008 | US20080031862 Mitochondria-targeted antioxidants |
| 02/07/2008 | US20080031861 Dietary supplements containing natural ingredients |
| 02/07/2008 | US20080031860 Compositions Comprising Pantothenic Acid or Derivatives Thereof and Their Use for Stimulating Appetite |
| 02/07/2008 | US20080031854 Thiolated macromolecules and methods of making and using thereof |
| 02/07/2008 | US20080031852 inhibitor of HCV NS5B polymerase; to treat infections caused by hepatitis C virus; 3-(1,1-Dioxo-1,4-dihydro-1 lambda 6-benzo[1,2,4]thiadiazin-3-yl)-4-hydroxy-1-(3-methyl-butyl)-pyrrolo[1,2-b]pyridazin-2-one |
| 02/07/2008 | US20080031851 Using a reovirus and chemotherapeutic agents to treat ras-activated neoplastic cells; proliferative disorders |
| 02/07/2008 | US20080031847 Methods and kits for treating lacerations and puncture wounds using inverse thermosensitive polymers |
| 02/07/2008 | US20080031846 Compositions with enhanced antimicrobial efficacy against acanthamoebae |
| 02/07/2008 | US20080031845 Personal care compositions that deposit hydrophilic benefit agents |
| 02/07/2008 | US20080031835 Antiinflammatory And Analgesic Preparation For External Use |
| 02/07/2008 | US20080031833 Combined energy and topical composition application for regulating the condition of mammalian skin |
| 02/07/2008 | US20080031830 Dental Composition Containing an Epoxy Functional Carbosilane Compound |
| 02/07/2008 | US20080031828 Method for the Treatment of Dyspnea Comprising Combined Administration of Tiotropium Salts and Salts of Salmeterol |
| 02/07/2008 | US20080031826 Devices containing lipid emulsions |
| 02/07/2008 | US20080031825 Pharmaceutical Compositions Comprising Effervescent Agents And Fenofibrate |
| 02/07/2008 | US20080031823 Agents for therapy efficacy monitoring and deep tissue imaging |
| 02/07/2008 | US20080031818 Use of Modulators of a Novel Form of Muscle Selective Calcineurin Interacting Protein (Mcip-1-38) as a Treatment for Cardiovascular Diseases |
| 02/07/2008 | US20080031817 Inhibition Of Superoxide Dismutase By Tetrathiomolybdate: Identification Of New Anti-Angiogenic And Antitumor Agents |
| 02/07/2008 | US20080031813 Targeted Combination Immunotherapy of Cancer and Infectious Diseases |
| 02/07/2008 | DE202007001059U1 Pharmazeutische Zubereitung für die Behandlung entzündlicher Erkrankungen des Urogenitaltraktes A pharmaceutical composition for the treatment of inflammatory diseases of the urogenital tract |
| 02/07/2008 | DE102006036579A1 Composition, useful to treat hypertension, comprises nebivolol as active agent and a polymer carrier material, where the active agent is present in micronized form in a polymer carrier matrix and is essentially free of wetting agent |
| 02/07/2008 | DE102006036326A1 Dendritische Polyglycerolsulfate und -sulfonate und deren Verwendung bei entzündlichen Erkrankungen Dendritic polyglycerol sulfates and sulfonates and the use thereof in inflammatory diseases |
| 02/07/2008 | DE102006036307A1 Medicament, useful to treat or prevent malignantly transformed cells, e.g. adeno-carcinoma, prostate carcinoma and breast carcinoma, comprises a mixture of quercetin and myrecetin and/or anisomycin and rapamycin as kinase inhibitors |
| 02/07/2008 | DE102006036023A1 Imino-imidazo-pyridinderivate mit antithrombotischer Aktivität Imino-imidazo-pyridine derivatives with antithrombotic activity |
| 02/07/2008 | DE102006035618A1 New nucleic acid useful as immuno-stimulating adjuvant for manufacture of a composition for treatment of cancer diseases e.g. colon carcinomas and infectious diseases e.g. influenza and malaria |
| 02/07/2008 | DE102005047558A1 Kombinationstherapie substituierter Oxazolidinone zur Prophylaxe und Behandlung von cerebralen Durchblutungsstörungen Combination therapy substituted oxazolidinones for the prophylaxis and treatment of cerebral circulatory disorders |
| 02/07/2008 | CA2663332A1 Iminoimidazopyridine derivatives having antithrombotic activity |
| 02/07/2008 | CA2663090A1 Business method to treat and/or prevent a gastric acid disorder with a proton pump inhibitor (ppi) and a cholinergic agonist to induce rapid onset of ppi action with or without food |
| 02/07/2008 | CA2660120A1 Agent for preventing infection |
| 02/07/2008 | CA2660052A1 Compositions and methods for the modulation of jnk proteins |
| 02/07/2008 | CA2660028A1 Substituted dimethylcyclobutyl compounds, their preparation and use in medicaments |
| 02/07/2008 | CA2660027A1 6-carboxy-normorphinan derivatives, synthesis and uses thereof |
| 02/07/2008 | CA2659971A1 Fused heterocyclic derivative and use thereof |
| 02/07/2008 | CA2659969A1 Pyrazolo[1,5-a]pyrimidines, processes, uses and compositions |
| 02/07/2008 | CA2659909A1 Treatment for chronic progressive heart failure |
| 02/07/2008 | CA2659905A1 Phytoestrogenic formulations and uses thereof |
| 02/07/2008 | CA2659880A1 Metallic nanoparticles and uses thereof as antimicrobials |
| 02/07/2008 | CA2659876A1 Pyrazolopyrimidines, a process for their preparation and their use as medicine |